Prot# VMDN-001: A Phase I/II Open Label, Dose-Escalation Study to Assess the Safety and Tolerability of VM202 in Patients with Painful Diabetic Peripheral Neuropathy
- Ajroud-Driss, Senda (Co-Investigator)
- Kessler, John (PD/PI)
Project: Research project